Five-Year Results With Patisiran for hATTR-PN
This open-label extension of a randomized clinical trial evaluates 5-year safety and efficacy of patisiran for the treatment of hereditary transthyretin amyloidosis with polyneuropathy.
Related Articles
NeuroBytes: Preconception & Reproductive Health in Epilepsy | AAN eLearning
Dashboard My Courses AAN.com NeuroBytes: PRECONCEPTION & REPRODUCTIVE HEALTH IN…
ASFNR-NMA Joint Award | ASFNR
ASFNR and NMA are very proud to announce a new, joint Award with the goal of increasing the number of underrepresented minority radiologists engaged in…
Disparate Use of Diagnostic Modalities for Patients With Limited English Proficiency and Neurologic Disorders | Neurology Clinical Practice
Background and ObjectivesLimited English proficiency (LEP) impairs health access—including outpatient specialty care—and quality care, i.e., inappropriate use of diagnostic tests. At least in some cases,…
Neurology Today
Neurology Today reports on breaking news, issues, and trends in the practice and science of neurolog
Frontiers | Editorial: Advancements in ultrasound for understanding the nervous system
As we approach the centennial of Harvey’s pioneering description of ultrasound’s eSects on the nervous system (Harvey 1929), this special collection …
Trends in School Mental Health and Substance Use Education
This study examines trends in school programming related to mental health and substance use and teacher professional development across US middle and high schools from…
Neurology Today
Neurology Today reports on breaking news, issues, and trends in the practice and science of neurology, reaching more than 36,000 professionals. It delivers credible, up-to-the-minute,…
Hypertensive Pregnancies Linked to Increased Risk of Neurologic Conditions – Practical Neurology
A Swedish register-based cohort study, published in JAMA Neurology, has found that women who experience gestational hypertension, preeclampsia, or ecl
Public Sharing of Adverse Events of Gene Therapy Trials
This Viewpoint describes the need for public sharing of adverse events associated with genetic therapies to improve patient safety.
UConn Health Candidate Self-Service
BROWSER NOT SUPPORTED – You are using an unsupported browser. Some features may not work correctly. CREATE AN ACCOUNT To apply for this position, choose…